Κυριακή 15 Μαρτίου 2020


Diffuse optical spectroscopic imaging reveals distinct early breast tumor hemodynamic responses to metronomic and maximum tolerated dose regimens.
Related ArticlesDiffuse optical spectroscopic imaging reveals distinct early breast tumor hemodynamic responses to metronomic and maximum tolerated dose regimens. Breast Cancer Res. 2020 Mar 13;22(1):29 Authors: Tank A, Peterson HM, Pera V, Tabassum S, Leproux A, O'Sullivan T, Jones E, Cabral H, Ko N, Mehta RS, Tromberg BJ, Roblyer D Abstract BACKGROUND: Breast cancer patients with early-stage disease are increasingly administered neoadjuvant chemotherapy...
pubmed: future oncology
Sun Mar 15, 2020 13:12
Future Oncology; +31 new citations
31 new pubmed citations were retrieved for your search. Click on the search hyperlink below to display the complete search results: Future Oncology These pubmed results were generated on 2020/03/14PubMed comprises more than millions of citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
pubmed: future oncology
Sat Mar 14, 2020 14:05
Future Oncology; +31 new citations
31 new pubmed citations were retrieved for your search. Click on the search hyperlink below to display the complete search results: Future Oncology These pubmed results were generated on 2020/03/14PubMed comprises more than millions of citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
pubmed: future oncology
Sat Mar 14, 2020 12:03
Systematic literature review of the global burden of illness of mantle cell lymphoma.
Related ArticlesSystematic literature review of the global burden of illness of mantle cell lymphoma. Curr Med Res Opin. 2020 Mar 12;:1 Authors: Monga N, Garside J, Quigley J, Hudson M, O'Donovan P, O'Rourke J, Tapprich C, Parisi L, Davids MS, Tam C Abstract Background Mantle cell lymphoma (MCL), a rare and aggressive disease, accounts for approximately 5% of all B-cell non-Hodgkin's lymphomas. Evidence on the burden of this disease, for patients...
pubmed: future oncology
Fri Mar 13, 2020 13:44
Mutation Variants and Co-Mutations as Genomic Modifiers of Response to Afatinib in HER2-Mutant Lung Adenocarcinoma.
Related ArticlesMutation Variants and Co-Mutations as Genomic Modifiers of Response to Afatinib in HER2-Mutant Lung Adenocarcinoma. Oncologist. 2020 Mar;25(3):e545-e554 Authors: Fang W, Zhao S, Liang Y, Yang Y, Yang L, Dong X, Zhang L, Tang Y, Wang S, Yang Y, Ma X, Wang M, Wang W, Zhao S, Wang K, Gao S, Zhang L Abstract BACKGROUND: Human epidermal growth factor receptor 2 (HER2)-mutant lung cancer remains an orphan of specific targeted therapy. The...
pubmed: future oncology
Fri Mar 13, 2020 13:44
Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial.
Related ArticlesPrognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial. Oncologist. 2020 Mar;25(3):e460-e468 Authors: Di Bartolomeo M, Morano F, Raimondi A, Miceli R, Corallo S, Tamborini E, Perrone F, Antista M, Niger M, Pellegrinelli A, Randon G, Pagani F,...
pubmed: future oncology
Fri Mar 13, 2020 13:44
Fracture Risk Assessment and Clinical Decision Making for Patients with Metastatic Bone Disease.
Related ArticlesFracture Risk Assessment and Clinical Decision Making for Patients with Metastatic Bone Disease. J Orthop Res. 2020 Mar 12;: Authors: Damron TA, Mann KA Abstract Metastatic breast, prostate, lung and other cancers often affect bone, causing pain, increasing fracture risk, and decreasing function. Management of metastatic bone disease (MBD) is clinically challenging when there is potential but uncertain risk of pathological fracture....
pubmed: future oncology
Fri Mar 13, 2020 13:44
Role of Cellular, Molecular, and Tumor Microenvironment in Hepatocellular Carcinoma: Possible Targets and Future Directions in the Regorafenib Era.
Related ArticlesRole of Cellular, Molecular, and Tumor Microenvironment in Hepatocellular Carcinoma: Possible Targets and Future Directions in the Regorafenib Era. Int J Cancer. 2020 Mar 12;: Authors: Juengpanich S, Topatana W, Lu C, Staiculescu D, Li S, Cao J, Lin J, Hu J, Chen M, Chen J, Cai X Abstract Hepatocellular carcinoma (HCC) remains as one of the major causes of cancer-related mortality, despite the recent development of new therapeutic...
pubmed: future oncology
Fri Mar 13, 2020 13:44
KEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBC.
Related ArticlesKEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBC. Future Oncol. 2020 Mar 12;: Authors: Kamat AM, Shore N, Hahn N, Alanee S, Nishiyama H, Shariat S, Nam K, Kapadia E, Frenkl T, Steinberg G Abstract Background: Nonmuscle-invasive bladder cancer (NMIBC) is the most common form of bladder cancer, with high rates of disease recurrence and progression. Current treatment for high-risk NMIBC involves...
pubmed: future oncology
Fri Mar 13, 2020 13:44
Primary immunodeficiencies and their associated risk of malignancies in children: an overview.
Related ArticlesPrimary immunodeficiencies and their associated risk of malignancies in children: an overview. Eur J Pediatr. 2020 Mar 11;: Authors: Renzi S, Langenberg-Ververgaert KPS, Waespe N, Ali S, Bartram J, Michaeli O, Upton J, Cada M Abstract Primary immunodeficiency disorders represent a heterogeneous spectrum of diseases, predisposing to recurrent infections, allergy, and autoimmunity. While an association between primary immunodeficiency...
pubmed: future oncology
Fri Mar 13, 2020 12:43
The in vivo role of Rev1 in mutagenesis and carcinogenesis.
Related ArticlesThe in vivo role of Rev1 in mutagenesis and carcinogenesis. Genes Environ. 2020;42:9 Authors: Sasatani M, Zaharieva EK, Kamiya K Abstract Translesion synthesis (TLS) is an error-prone pathway required to overcome replication blockage by DNA damage. Aberrant activation of TLS has been suggested to play a role in tumorigenesis by promoting genetic mutations. However, the precise molecular mechanisms underlying TLS-mediated tumorigenesis...
pubmed: future oncology
Fri Mar 13, 2020 12:43
Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer.
Related ArticlesSerial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer. Sci Rep. 2020 Mar 11;10(1):4484 Authors: Larsson AM, Bendahl PO, Aaltonen K, Jansson S, Forsare C, Bergqvist M, Jørgensen CLT, Rydén L Abstract The rapid development of new therapies in metastatic breast cancer (MBC), entails a need for improved prognostic and monitoring tools. Thymidine kinase 1 (TK1) is involved...
pubmed: future oncology
Fri Mar 13, 2020 12:43
[Current status and prospects of clinical research on diagnosis and treatment of gastric cancer in China].
Related Articles[Current status and prospects of clinical research on diagnosis and treatment of gastric cancer in China]. Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Feb 25;23(2):109-114 Authors: Xu HM, Wang X Abstract As early as in the 1960s, China has begun to conduct exploratory clinical researches on gastric cancer. In the past 10 years, the research projects have increased significantly. Among them, the minimally invasive surgery represented by laparoscopy...
pubmed: future oncology
Fri Mar 13, 2020 12:43
High information content assays for genetic toxicology testing: A report of the International Workshops on Genotoxicity Testing (IWGT).
Related ArticlesHigh information content assays for genetic toxicology testing: A report of the International Workshops on Genotoxicity Testing (IWGT). Mutat Res. 2019 11;847:403022 Authors: Dertinger SD, Totsuka Y, Bielas JH, Doherty AT, Kleinjans J, Honma M, Marchetti F, Schuler MJ, Thybaud V, White P, Yauk CL Abstract We live in an era of 'big data', where the volume, velocity, and variety of the data being generated is increasingly influencing the...
pubmed: future oncology
Fri Mar 13, 2020 12:43
Elective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis.
Related ArticlesElective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis. Radiat Oncol. 2019 Oct 16;14(1):176 Authors: Liu T, Ding S, Dang J, Wang H, Chen J, Li G Abstract BACKGROUND: To assess the comparative efficacy and safety of elective nodal irradiation (ENI) and involved-field irradiation (IFI) in patients with esophageal cancer (EC) receiving...
pubmed: future oncology
Fri Mar 13, 2020 12:43
Drug holiday clinical relevance verification for antiresorptive agents in medication-related osteonecrosis cases of the jaw.
Related ArticlesDrug holiday clinical relevance verification for antiresorptive agents in medication-related osteonecrosis cases of the jaw. J Bone Miner Metab. 2020 Jan;38(1):126-134 Authors: Hayashida S, Yanamoto S, Fujita S, Hasegawa T, Komori T, Kojima Y, Miyamoto H, Shibuya Y, Ueda N, Kirita T, Nakahara H, Shinohara M, Kondo E, Kurita H, Umeda M Abstract Treatment strategies of medication-related osteonecrosis of the jaw (MRONJ) are controversial....
pubmed: future oncology
Fri Mar 13, 2020 12:43
Measurements for Sulfide-Mediated Inhibition of Myeloperoxidase Activity.
Related ArticlesMeasurements for Sulfide-Mediated Inhibition of Myeloperoxidase Activity. Methods Mol Biol. 2019;2007:179-203 Authors: Garai D, Pálinkás Z, Balla J, Kettle AJ, Nagy P Abstract Oxidative stress-alleviating and inflammation-mediatory functions of hydrogen sulfide were reported to be key features of its biological actions. However, the underlying molecular mechanisms of these biological observations are not fully understood. In conditions...
pubmed: future oncology
Fri Mar 13, 2020 12:43
The trajectory of patients who die from metastatic prostate cancer: a population-based study.
Related ArticlesThe trajectory of patients who die from metastatic prostate cancer: a population-based study. BJU Int. 2019 05;123 Suppl 5:19-26 Authors: Collins A, Sundararajan V, Millar J, Burchell J, Le B, Krishnasamy M, McLachlan SA, Hudson P, Mileshkin L, Philip J Abstract OBJECTIVES: To describe health service use, symptom and survival characteristics in metastatic prostate cancer (mPCa) in order to outline usual care practices and identify future...
pubmed: future oncology
Fri Mar 13, 2020 12:43
Interest in Learning About Fertility Status Among Male Adolescent and Young Adult Survivors of Childhood Cancer.
Related ArticlesInterest in Learning About Fertility Status Among Male Adolescent and Young Adult Survivors of Childhood Cancer. J Adolesc Young Adult Oncol. 2019 02;8(1):61-66 Authors: Ferrante AC, Gerhardt CA, Yeager ND, Rausch JR, Lehmann V, O'Brien S, Quinn GP, Nahata L Abstract PURPOSE: As many as two-thirds of male childhood cancer survivors are at risk for fertility impairment as a consequence of treatment. Despite this, survivorship guidelines...
pubmed: future oncology
Fri Mar 13, 2020 12:43
Patient and Physician Perspective on Sperm Banking to Overcome Post-Treatment Infertility in Young Cancer Patients in Pakistan.
Related ArticlesPatient and Physician Perspective on Sperm Banking to Overcome Post-Treatment Infertility in Young Cancer Patients in Pakistan. J Adolesc Young Adult Oncol. 2019 02;8(1):54-60 Authors: Latif N, Ali N Abstract BACKGROUND: Cancer survivor rates have increased over the past few decades leading to a growing interest in research related to quality of life (QoL). We attempted to explore the unique barriers that might prevent adult male...
pubmed: future oncology
Fri Mar 13, 2020 12:43
Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes.
Related ArticlesDifferential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes. Cancer Immunol Immunother. 2020 Mar 13;: Authors: Zahran AM, Hetta HF, Rayan A, Eldin AS, Hassan EA, Fakhry H, Soliman A, El-Badawy O Abstract BACKGROUND AND OBJECTIVE: Activation of the immune checkpoints and expression of chemokines and chemokine receptors have...
Oncology
Sun Mar 15, 2020 13:03
Circulating leptin levels are associated with adiposity in survivors of childhood brain tumors.
Related ArticlesCirculating leptin levels are associated with adiposity in survivors of childhood brain tumors. Sci Rep. 2020 Mar 13;10(1):4711 Authors: Sims ED, Jennings WJ, Empringham B, Fleming A, Portwine C, Johnston DL, Zelcer SM, Rassekh SR, Burrow S, Thabane L, Samaan MC Abstract Survivors of Childhood Brain Tumors (SCBT) are at a higher risk of developing cardiovascular disease and type 2 diabetes compared to the general population. Adiposity...
Oncology
Sun Mar 15, 2020 13:03
Design and development of 99mTc labeled FAPI-tracers for SPECT-imaging and 188Re therapy.
Related ArticlesDesign and development of 99mTc labeled FAPI-tracers for SPECT-imaging and 188Re therapy. J Nucl Med. 2020 Mar 13;: Authors: Lindner T, Altmann A, Kraemer S, Kleist C, Loktev A, Kratochwil C, Giesel F, Mier W, Marme F, Debus J, Haberkorn U Abstract The majority of epithelial tumors recruits fibroblasts and other non-malignant cells and activates them into cancer-associated fibroblasts. This often leads to overexpression of the membrane...
Oncology
Sun Mar 15, 2020 13:03
Dysphagia prevalence and associated survival differences in older patients with lung Cancer: A SEER-Medicare population-based study.
Related ArticlesDysphagia prevalence and associated survival differences in older patients with lung Cancer: A SEER-Medicare population-based study. J Geriatr Oncol. 2020 Mar 10;: Authors: Marmor S, Cohen S, Fujioka N, Cho LC, Bhargava A, Misono S Abstract INTRODUCTION: The impact of dysphagia in persons with lung cancer is unknown. The objective of this study is to measure the prevalence and survival differences associated with dysphagia in older adults...
Oncology
Sun Mar 15, 2020 13:03
Age differences in patterns and confidence of using internet and social media for cancer-care among cancer survivors.
Related ArticlesAge differences in patterns and confidence of using internet and social media for cancer-care among cancer survivors. J Geriatr Oncol. 2020 Mar 10;: Authors: Eng L, Bender J, Hueniken K, Kassirian S, Mitchell L, Aggarwal R, Paulo C, Smith EC, Geist I, Balaratnam K, Magony A, Liang M, Yang D, Jones JM, Brown MC, Xu W, Grover SC, Alibhai SMH, Liu G, Gupta AA Abstract OBJECTIVES: The internet and social media provide information and support...
Oncology
Sun Mar 15, 2020 13:03
A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy versus Two Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical Cancer.
Related ArticlesA Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy versus Two Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Phys. 2020 Mar 10;: Authors: Perdrizet J, D'Souza D, Skliarenko J, Ang M, Barbera L, Gutierrez E, Ravi A, Tanderup K, Warde P, Chan KKW, Isaranuwatchai W, Milosevic M Abstract BACKGROUND: and Purpose: The standard treatment for locally...
Oncology
Sun Mar 15, 2020 13:03
Pediatric Robotic Surgery.
Related ArticlesPediatric Robotic Surgery. Surg Clin North Am. 2020 Apr;100(2):431-443 Authors: Denning NL, Kallis MP, Prince JM Abstract Pediatric robotic-assisted surgery is quickly gaining traction in pediatric surgical disciplines but presents unique challenges as compared to adult robotic surgery. Small abdominal and thoracic cavities limit working space and operative indications differ from the adult population. This article describes the development...
Oncology
Sun Mar 15, 2020 13:03
Therapeutic targeting of the DNA damage response in prostate cancer.
Related ArticlesTherapeutic targeting of the DNA damage response in prostate cancer. Curr Opin Oncol. 2020 Mar 09;: Authors: Marshall CH, Antonarakis ES Abstract PURPOSE OF REVIEW: The present article highlights the most common DNA repair gene mutations, using specific examples of individual genes or gene classes, and reviews the epidemiology and treatment implications for each one [with particular emphasis on poly-ADP-ribose polymerase (PARP) inhibition...
Oncology
Sat Mar 14, 2020 12:52
"My Research Is Their Business, but I'm Not Their Business": Patient and Clinician Perspectives on Commercialization of Precision Oncology Data.
Related Articles"My Research Is Their Business, but I'm Not Their Business": Patient and Clinician Perspectives on Commercialization of Precision Oncology Data. Oncologist. 2020 Mar 13;: Authors: Spector-Bagdady K, Krenz CD, Brummel C, Brenner JC, Bradford CR, Shuman AG Abstract BACKGROUND: Genetic sequencing and precision oncology have supported clinical breakthroughs but depend upon access to vast arrays of research specimens and data. One way for...
Oncology
Sat Mar 14, 2020 12:52
Rethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysis.
Related ArticlesRethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysis. Cancer. 2020 Mar 13;: Authors: Broughman JR, Xiong DD, Moeller BJ, Contrera KJ, Prendes BL, Lamarre ED, Ku JA, Burkey BB, Woody NM, Joshi NP, Adelstein DJ, Geiger JL, Frenkel CH, Milas ZL, Brickman DS, Sumrall AL, Carrizosa DR, Greskovich JF, Koyfman SA, Ward MC Abstract BACKGROUND: De-intensified treatment...
Oncology
Sat Mar 14, 2020 12:52
MIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine ± idasanutlin in relapsed or refractory acute myeloid leukemia.
Related ArticlesMIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine ± idasanutlin in relapsed or refractory acute myeloid leukemia. Future Oncol. 2020 Mar 13;: Authors: Montesinos P, Beckermann BM, Catalani O, Esteve J, Gamel K, Konopleva MY, Martinelli G, Monnet A, Papayannidis C, Park A, Récher C, Rodríguez-Veiga R, Röllig C, Vey N, Wei AH, Yoon SS, Fenaux P Abstract Patients with refractory or relapsed acute myeloid leukemia (R/R...
Oncology
Sat Mar 14, 2020 12:52
Update on molecular companion diagnostics - a future in personalized medicine beyond Sanger sequencing.
Related ArticlesUpdate on molecular companion diagnostics - a future in personalized medicine beyond Sanger sequencing. Expert Rev Mol Diagn. 2020 Mar 13;: Authors: Campbell MR Abstract Introduction: The merging of molecular diagnostics with personalized medicine has led to a surge in development of molecular-based companion diagnostics. Companion diagnostics, defined as "a medical device, often an in vitro device, which provides information that is...
Oncology
Sat Mar 14, 2020 12:52
High Impact Physical Activity and Bone Health of Lower Extremities in Childhood Cancer Survivors: A Cross-sectional Study of SURfit.
Related ArticlesHigh Impact Physical Activity and Bone Health of Lower Extremities in Childhood Cancer Survivors: A Cross-sectional Study of SURfit. Int J Cancer. 2020 Mar 13;: Authors: Zürcher SJ, Jung R, Monnerat S, Schindera C, Eser P, Meier C, Rueegg CS, von der Weid NX, Kriemler S Abstract Childhood cancer survivors (CCS) are at risk of reduced bone health and premature osteoporosis. As physical activity with high impact loading (IL-PA) is known...
Oncology
Sat Mar 14, 2020 12:52
The Phys-Can study: meaningful and challenging - supervising physical exercise in a community-based setting for persons undergoing curative oncological treatment.
Related ArticlesThe Phys-Can study: meaningful and challenging - supervising physical exercise in a community-based setting for persons undergoing curative oncological treatment. Physiother Theory Pract. 2020 Mar 13;:1-10 Authors: Henriksson A, Igelström H, Arving C, Nordin K, Johansson B, Demmelmaier I Abstract Introduction: Supervised exercise may improve physical function and quality of life during oncological treatment. Providing supervised exercise...
Oncology
Sat Mar 14, 2020 12:52
Poly(ADP-ribose) polymerase inhibitors as maintenance treatment in patients with newly diagnosed advanced ovarian cancer: a meta-analysis.
Related ArticlesPoly(ADP-ribose) polymerase inhibitors as maintenance treatment in patients with newly diagnosed advanced ovarian cancer: a meta-analysis. Future Oncol. 2020 Mar 13;: Authors: Ibrahim EM, Refae AA, Bayer AM, Sagr ER Abstract Aim: Poly(ADP-ribose) polymerase inhibitors (PARPIs) improved progression-free survival among patients with recurrent ovarian cancer. This meta-analysis examined the effectiveness of PARPIs as maintenance strategy...
Oncology
Sat Mar 14, 2020 12:52
Prognostic value of systemic inflammatory marker in patients with head and neck squamous cell carcinoma undergoing surgical resection.
Related ArticlesPrognostic value of systemic inflammatory marker in patients with head and neck squamous cell carcinoma undergoing surgical resection. Future Oncol. 2020 Mar 13;: Authors: Zhou S, Yuan H, Wang J, Hu X, Liu F, Zhang Y, Jiang B, Zhang W Abstract Aim: To explore the prognostic value of the systemic inflammatory marker (SIM) based on neutrophil, lymphocyte and monocyte counts in head and neck squamous cell carcinoma (HNSCC) patients. Patients...
Oncology
Sat Mar 14, 2020 12:52
Mood disorders and outcomes in lung cancer patients undergoing surgery: a brief summery.
Related ArticlesMood disorders and outcomes in lung cancer patients undergoing surgery: a brief summery. Future Oncol. 2020 Mar 13;: Authors: Signorelli MS, Surace T, Migliore M, Aguglia E Abstract Cancer is a leading cause of death worldwide. Literature reports depression and anxiety are the most common psychiatric symptoms in cancer patients. Notably, lung cancer is associated with major depressive disorder in 5-13% of cases. The present article aims...
Oncology
Sat Mar 14, 2020 12:52
Bortezomib for autoimmune hemolytic anemia after intestinal transplantation.
Related ArticlesBortezomib for autoimmune hemolytic anemia after intestinal transplantation. Pediatr Transplant. 2020 Mar 12;:e13700 Authors: Knops N, Emonds MP, Herman J, Levtchenko E, Mekahli D, Pirenne J, Van Geet C, Dierickx D Abstract AIHA is rare in the general population and associated with a mortality of 8%. In contrast, AIHA occurs in up to 12.2% of cases after intestinal transplantation and is associated with mortality up to 50%. Treatment...
Oncology
Sat Mar 14, 2020 12:52

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου